Omnicell Stock Analysis

Omnicell Stock Analysis Notes

About 98.0% of the company shares are owned by institutional investors. The company has price-to-book ratio of 1.66. Typically companies with comparable Price to Book (P/B) are able to outperform the market in the long run. Omnicell has Price/Earnings To Growth (PEG) ratio of 2.28. The entity recorded a loss per share of 0.39. The firm had not issued any dividends in recent years. Omnicell, Inc., together with its subsidiaries, provides medication management solutions and adherence tools for healthcare systems and pharmacies the United States and internationally. Omnicell, Inc. was incorporated in 1992 and is headquartered in Mountain View, California. Omnicell operates under Health Information Services classification in the United States and is traded on NASDAQ Exchange. It employs 4000 people. To find out more about Omnicell contact Randall Lipps at 877 415 9990 or learn more at https://www.omnicell.com.

Omnicell Investment Alerts

Omnicell Upcoming and Recent Events

Omnicell Largest EPS Surprises

View All Earnings Estimates

Omnicell Environmental, Social, and Governance (ESG) Scores

Omnicell Stock Institutional Investors

Note, although Omnicell's institutional investors appear to be way more sophisticated than retail investors, it remains unclear if professional active investment managers can reliably enhance risk-adjusted returns by an amount that exceeds fees and expenses.

Omnicell Market Capitalization

The company currently falls under 'Mid-Cap' category with a current market capitalization of 2.04 B.

Omnicell Profitablity

The company has Profit Margin (PM) of (0.02) %, which may suggest that it does not properly executes on its current pricing strategies or is unable to control all of the operational costs. This is way below average. Similarly, it shows Operating Margin (OM) of 0.03 %, which suggests for every 100 dollars of sales, it generated a net operating income of $0.03.

Management Efficiency

Return On Tangible Assets is expected to rise to -0.02 this year. Return On Capital Employed is expected to rise to -0.02 this year. At this time, Omnicell's Intangible Assets are quite stable compared to the past year. Net Tangible Assets is expected to rise to about 297.7 M this year, although the value of Return On Tangible Assets are projected to rise to (0.02). Omnicell's management efficiency ratios could be used to measure how well Omnicell manages its routine affairs as well as how well it operates its assets and liabilities.

Technical Drivers

As of the 22nd of November, Omnicell holds the Risk Adjusted Performance of 0.0275, coefficient of variation of 3980.82, and Semi Deviation of 2.52. Compared to fundamental indicators, the technical analysis model allows you to check existing technical drivers of Omnicell, as well as the relationship between them. Please check Omnicell treynor ratio, as well as the relationship between the downside variance and kurtosis to decide if Omnicell is priced some-what accurately, providing market reflects its current price of 45.69 per share. Given that Omnicell has jensen alpha of (0.02), we recommend you to check out Omnicell's recent market performance to make sure the company can sustain itself at a future point.

Omnicell Price Movement Analysis

Omnicell Insider Trading Activities

Omnicell Outstanding Bonds

Omnicell Predictive Daily Indicators

Omnicell Corporate Filings

Omnicell Forecast Models

Omnicell's time-series forecasting models are one of many Omnicell's stock analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Omnicell's historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.

Stock analysis is the technique used by a trader or investor to examine and evaluate how Omnicell prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Omnicell shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Stock such as Omnicell. By using and applying Omnicell Stock analysis, traders can create a robust methodology for identifying Omnicell entry and exit points for their positions.

We track the performance of the top 100 financial experts across various large and mid-size financial boutiques. Omnicell analyst recommendations are determined by taking all analyst recommendations and averaging them as Strong Buy, Buy, Hold, Strong Sell or Sell. There is no one specific way to measure analysis performance other than comparing it to the past results via a very sophisticated attribution analysis. Omnicell analyst consensus and target price projections should be used in combination with other traditional techniques such as stock price forecasting, technical analysis, earnings estimate, and various momentum models.

Omnicell stock analysis indicators help investors evaluate how Omnicell stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing and determine when trading Omnicell shares will generate the highest return on investment. By understating and applying Omnicell stock analysis, traders can identify Omnicell position entry and exit signals to maximize returns.

Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Omnicell. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in main economic indicators. For more information on how to buy Omnicell Stock please use our How to buy in Omnicell Stock guide.You can also try the Equity Analysis module to research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities.

Is Health Care Technology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Omnicell. If investors know Omnicell will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Omnicell listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.

The market value of Omnicell is measured differently than its book value, which is the value of Omnicell that is recorded on the company's balance sheet. Investors also form their own opinion of Omnicell's value that differs from its market value or its book value, called intrinsic value, which is Omnicell's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Omnicell's market value can be influenced by many factors that don't directly affect Omnicell's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.

Please note, there is a significant difference between Omnicell's value and its price as these two are different measures arrived at by different means. Investors typically determine if Omnicell is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Omnicell's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.